|
|
Asia-Pacific's Growing Role in Global Clinical TrialsPublished by: CenterWatch Published: Mar. 1, 2008 - 168 Pages Table of Contents
AbstractGlobal clinical trials initiated in the Asia-Pacific region increased 50% between 2005 and 2006, a dramatic one year spurt of growth led by Taiwan, Korea and India. But this will not be an isolated incident. Countries in the region have continued to make changes for the better in their respective clinical research environments to allow for even more growth. With strong economic drivers, more than one-third the earth’s population and inherent challenges being addressed by an increasingly savvy industry, there is no end in sight for the Asia- Pacific region’s growth in clinical research.Although the Asia-Pacific region comprises countries that are markedly different from each other, those countries share important commonalities that attract big pharma and biotech to the region to conduct clinical research. Drivers include the requirements for greater numbers of patients for clinical trials that have become increasingly complex, faster patient enrollment times and the fact that some countries are emerging as large economic powers. In addition, because investigative sites in Asia Pacific have significantly fewer enrollment delays of one month or more compared with the U.S., according to the CenterWatch 2006 survey of investigative sites in Asia-Pacific, the cost savings to be gained from conducting clinical research in the region are substantial. Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||